| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |